Company
Clarametyx
Transforming treatment for chronic respiratory disease
Also known as Clarametyx Biosciences, CLARAMETYX BIOSCIENCES, INC.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Columbus, Ohio, United States
- Founded
- 2020
- Legal name
- CLARAMETYX BIOSCIENCES, INC.
Record updated 28 September 2026
About
Clarametyx Biosciences is combating the formidable challenge of chronic respiratory diseases through an innovative technology platform targeting the biofilm—a protective layer around bacteria that drives inflammation and disease exacerbation.
Funding snapshot
- Total raised
- $27.5MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $27.5M2024-01-05
Funding rounds
- Round, 2024
- $27.5M2024-01-05, SEC form D sold, 7 investors
Products
- Other
- CMTX-101
- Other
- CMTX-301